CUBE vs TXG · P/E 25, rev $1.07B vs rev $610.8M
CubeSmart (CUBE) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TXG currently screens at market cap $4.08B.
Not investment advice. Open the CUBE and TXG stock pages for the full models.
Not investment advice.